MindMed Announces 2021 Q1 Financial Results May 14 • 3 min read Mind Medicine (MindMed) Inc. has announced its quarterly financial results for the quarter ended March 31, 2021.
MindMed Bolsters Management Team May 13 • 2 min read MindMed has appointed Peter Mack PhD as Vice President of Pharmaceutical Development.
Delic’s Acquisition Target to Acquire 2 Additional Clinic Locations May 12 • 4 min read Delic Holdings Inc. announced that its acquisition target proposes to acquire two additional licensed ketamine clinics in Arizona.
Wesana Health Commences Trading on the CSE May 10 • 1 min read Wesana Health Holdings Inc. announced that its shares will commence trading on the Canadian Securities Exchange (“CSE”).
Braxia Scientific Introduces “Braxia Health” a Growing Network of Clinics Leading Psychedelic Research May 6 • 3 min read Braxia Scientific Corp. is pleased to announce the rebranding of its growing network of research and treatment clinics to Braxia Health.